Search

Displaying results 3891 - 3900 of 10000 in total
  1. Drug

    Ustilago cynodontis

    go.drugbank.com/drugs/DB10834
    Approved

    Ustilago cynodontis extract is used in allergenic testing.

    Categories: Non-Standardized Fungal Allergenic Extract
  2. Drug

    Phycomyces blakesleeanus

    go.drugbank.com/drugs/DB10845
    Approved

    Phycomyces blakesleeanus extract is used in allergenic testing.

    Categories: Non-Standardized Fungal Allergenic Extract
  3. Drug

    Sporotrichum pruinosum

    go.drugbank.com/drugs/DB10846
    Approved

    Sporotrichum pruinosum extract is used in allergenic testing.

    Categories: Non-Standardized Fungal Allergenic Extract
  4. Drug

    Stachybotrys chartarum

    go.drugbank.com/drugs/DB10847
    Approved

    Stachybotrys chartarum extract is used in allergenic testing.

    Categories: Non-Standardized Fungal Allergenic Extract
  5. Drug

    Syncephalastrum racemosum

    go.drugbank.com/drugs/DB10848
    Approved

    Syncephalastrum racemosum extract is used in allergenic testing.

    Categories: Non-Standardized Fungal Allergenic Extract
  6. Drug

    Epidermophyton floccosum

    go.drugbank.com/drugs/DB10870
    Approved

    Epidermophyton floccosum extract is used in allergenic testing.

    Categories: Non-Standardized Fungal Allergenic Extract
  7. Drug

    Pleospora betae

    go.drugbank.com/drugs/DB10936
    Approved

    Pleospora betae extract is used in allergenic testing.

    Categories: Non-Standardized Fungal Allergenic Extract
  8. Drug

    Trichophyton tonsurans

    go.drugbank.com/drugs/DB10970
    Approved

    Trichophyton tonsurans extract is used in allergenic testing.

    Categories: Non-Standardized Fungal Allergenic Extract
  9. Drug

    Robenacoxib

    go.drugbank.com/drugs/DB11455
    ExperimentalVet approved

    Robenacoxib is a non-steroidal anti-inflammatory drug used in veterinary medicine for the relief of pain and inflammation in cats and dogs.

    Categories: Anti-Inflammatory Agents, Non-Steroidal
  10. Drug

    Nirogacestat

    go.drugbank.com/drugs/DB12005
    ApprovedInvestigational

    It was previously granted breakthrough therapy, fast track, and orphan drug designations for the treatment of desmoid tumors, and the final approval was based on positive results obtained in the Phase … [A262561] Nirogacestat was approved under the brand name OGSIVEO on November 27, 2023, by the FDA for the treatment of adult patients with progressing desmoid tumors who require systemic treatment.